Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 17.36B | 17.72B | 17.60B | 24.70B | 23.10B | 16.21B |
Gross Profit | 5.09B | 1.31B | 1.14B | 1.87B | 1.61B | 1.17B |
EBITDA | 807.40M | 762.26M | 613.59M | 1.36B | 1.17B | 775.00M |
Net Income | 508.09M | 465.69M | 325.13M | 940.52M | 844.25M | 506.42M |
Balance Sheet | ||||||
Total Assets | 5.23B | 5.30B | 5.23B | 5.95B | 7.03B | 5.14B |
Cash, Cash Equivalents and Short-Term Investments | 129.94M | 145.76M | 145.52M | 217.48M | 257.41M | 243.80M |
Total Debt | 1.73B | 1.74B | 1.95B | 2.36B | 2.23B | 1.43B |
Total Liabilities | 3.49B | 3.58B | 3.81B | 4.60B | 5.01B | 3.26B |
Stockholders Equity | 1.73B | 1.72B | 1.42B | 1.35B | 2.02B | 1.88B |
Cash Flow | ||||||
Free Cash Flow | 606.29M | 486.43M | 647.84M | 1.52B | 24.03M | 445.18M |
Operating Cash Flow | 648.94M | 509.08M | 731.95M | 1.65B | 94.95M | 499.19M |
Investing Cash Flow | -40.16M | -74.29M | -82.79M | -64.92M | -85.67M | -271.71M |
Financing Cash Flow | -597.00M | -416.10M | -717.83M | -1.62B | 7.57M | -440.67M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $16.21B | 19.65 | 37.70% | 1.30% | 24.07% | 27.40% | |
70 Outperform | $15.57B | 40.66 | 26.24% | ― | 1.94% | 60.91% | |
70 Neutral | $11.64B | 23.42 | 32.11% | 2.53% | -0.22% | 65.52% | |
69 Neutral | $2.19B | 20.95 | 6.35% | 1.40% | -4.63% | -18.94% | |
69 Neutral | $15.16B | 27.76 | 13.97% | 1.15% | -3.82% | -12.80% | |
66 Neutral | $5.10B | 28.93 | 18.34% | 1.10% | -4.72% | -22.46% | |
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% |
C.H. Robinson held its 2025 Annual Meeting of Shareholders virtually on May 8, 2025, where approximately 90% of outstanding shares were represented. During the meeting, shareholders elected ten directors for one-year terms, approved executive compensation on a non-binding basis, ratified Deloitte & Touche LLP as the independent accounting firm for 2025, and approved the amended 2022 Equity Incentive Plan.
The most recent analyst rating on (CHRW) stock is a Hold with a $92.00 price target. To see the full list of analyst forecasts on CH Robinson stock, see the CHRW Stock Forecast page.